1. I wouldn't call planning the successful implementation of the $40M plus drilling program - FMDP as "doing FA" in the last 10 months.
2. My understanding is that the Buy Back saw the business pay the market average price for the shares over the Buy Back period. What was poor about the process apart from BRK not buying up to the limit allowed? Did you want them to buy the shares at a figure above the average, remembering it is your money they were spending?
3. The Only director "requesting" shares is DP and those shares are in lieu of salary and supportted by a report from an Independent Remuneration Consultant. They are not "performance shares".
4. Happy for you to explain what an "Agreed Price" is in a "Buy Back". There is no Agreed Price there is only a maximum price - no more than 5% above the 5 day VWAP.
5. How did the Buy Back push the price lower? If BRK had not bought the shares it did when it did then in all likelihood the share price would have been lower throughout the entire Buy Back period.
- Forums
- ASX - By Stock
- BRK
- Banter and General Comments .. BRK
Banter and General Comments .. BRK, page-11520
-
-
- There are more pages in this discussion • 786 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRK (ASX) to my watchlist
(20min delay)
|
|||||
Last
49.5¢ |
Change
-0.030(5.71%) |
Mkt cap ! $47.72M |
Open | High | Low | Value | Volume |
52.0¢ | 52.0¢ | 49.0¢ | $37.84K | 75.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 32116 | 49.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 68954 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 32116 | 0.490 |
1 | 160 | 0.485 |
1 | 5000 | 0.475 |
2 | 11706 | 0.470 |
1 | 1101 | 0.455 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 68954 | 1 |
0.505 | 1900 | 1 |
0.520 | 94 | 1 |
0.525 | 42076 | 2 |
0.530 | 1300 | 1 |
Last trade - 12.49pm 13/11/2024 (20 minute delay) ? |
Featured News
BRK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online